Orthodontics and Thyroid Conditions UK

Thyroid function and bone metabolism

The thyroid gland produces two main hormones: thyroxine (T4) and triiodothyronine (T3), which regulate metabolism throughout the body including bone metabolism. Thyroid hormones stimulate osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells). In the context of orthodontics, bone remodelling — the controlled resorption on the pressure side and deposition on the tension side of a moving tooth — is the fundamental biological process that allows teeth to move through bone. Any condition that alters the balance of bone turnover can theoretically affect the rate, predictability, or safety of orthodontic tooth movement. The clinical significance of thyroid conditions for most orthodontic patients is modest, particularly when the condition is well controlled with medication.

Hypothyroidism and orthodontic treatment

Hypothyroidism — underactive thyroid — results in reduced circulating thyroid hormone. The consequences for bone metabolism include reduced bone turnover: both formation and resorption are slowed. In the context of orthodontic treatment, this theoretically means that tooth movement may be slower than average, as the remodelling response to orthodontic forces may be blunted. Clinically significant delays are reported anecdotally, but high-quality controlled studies are limited. Untreated or severely undertreated hypothyroidism is also associated with delayed wound healing, increased susceptibility to infection, and cardiovascular effects that would be relevant if extractions are needed. For patients whose hypothyroidism is well controlled on levothyroxine replacement therapy with a normal TSH, the impact on orthodontic tooth movement is generally minimal.

Hyperthyroidism and orthodontic treatment

Hyperthyroidism — overactive thyroid — produces elevated thyroid hormone levels and accelerates bone metabolism. Increased osteoclast activity leads to net bone resorption and reduced bone mineral density over time, which can increase the risk of root resorption during orthodontic treatment. Root resorption (shortening of tooth roots) is a recognised risk of orthodontic treatment, particularly with heavy continuous forces or prolonged treatment. While the evidence base is not definitive, some researchers suggest that untreated or poorly controlled hyperthyroidism may increase root resorption risk and reduce bone support. Cardiovascular effects of hyperthyroidism (palpitations, arrhythmias) are relevant if general anaesthesia is ever required for associated procedures. Well-controlled hyperthyroidism (euthyroid on medication) has a much lower risk profile.

Levothyroxine and orthodontic treatment

Levothyroxine (brand name Eltroxin or Levothyroxine tablets in the UK) is the standard replacement therapy for hypothyroidism. When the dose is optimised and TSH is within the normal reference range, patients are effectively euthyroid — their thyroid hormone levels are normalised. In this well-controlled state, levothyroxine itself does not directly interact with orthodontic treatment in a clinically meaningful way. There is no evidence that levothyroxine impairs or accelerates tooth movement beyond the effect of any residual under- or over-treatment of thyroid function. Patients should take levothyroxine at the same time each day, separate from calcium-containing supplements (which can reduce absorption), and attend their regular GP or endocrinology reviews to ensure TSH remains in range during orthodontic treatment.

What to tell your orthodontist

Always disclose any thyroid condition and any thyroid medication at your initial orthodontic consultation. Provide the name and dose of the medication (e.g., levothyroxine 100 mcg daily), the underlying diagnosis, and when it was diagnosed and how well controlled it is. If you have regular blood tests (TSH, T4), your most recent result date is useful. If your thyroid condition has been recently diagnosed or your dose has recently changed, let the orthodontist know. This information is included in your medical history form and informs risk assessment — particularly regarding rate of movement, root resorption risk, and healing — which affects how the orthodontist plans and monitors your treatment.

Monitoring during treatment

For patients with thyroid conditions, your orthodontist may recommend slightly more frequent monitoring radiographs (such as periapical X-rays at intervals) to check for root resorption, particularly if treatment is extended or heavy forces are being used. Continue attending your GP or endocrinology appointments during orthodontic treatment — do not let orthodontic appointments displace thyroid monitoring. If your thyroid status changes significantly during treatment (a new diagnosis, dose adjustment, or development of symptoms), inform your orthodontist promptly. Changes in thyroid status during treatment are relevant to ongoing risk assessment.

Thyroid cancer treatment and orthodontics

Patients who have been treated for thyroid cancer may have received radioactive iodine (I-131) ablation therapy or external beam radiotherapy to the neck region. External beam radiotherapy to the head and neck can reduce salivary gland function (causing xerostomia — dry mouth), alter bone density in the jaw, and affect wound healing and mucosal integrity. These effects are relevant to orthodontic treatment and particularly to any extractions. Radioactive iodine (I-131) is primarily concentrated in thyroid tissue and does not produce the same bone and soft tissue effects as external beam radiotherapy, so its orthodontic implications are more limited. Patients who have had head and neck radiotherapy should discuss this history with their orthodontist and may require closer liaison with their oncology team.

No contraindication when well controlled

The overarching clinical message is that thyroid conditions do not contraindicate orthodontic treatment. For patients whose thyroid function is well controlled on medication and who have a normal or near-normal TSH, orthodontic treatment can proceed using standard protocols. The orthodontist will factor in the condition when discussing treatment risks and may adjust monitoring frequency. Most patients with hypothyroidism or treated hyperthyroidism have perfectly successful orthodontic treatment outcomes comparable to patients without thyroid conditions.

Useful related pages

This guide is for general information only. It is not a diagnosis, treatment plan, or substitute for advice from a registered dentist or orthodontist.